Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetasel

Similar documents
PORPHYRINS AND PORPHYRIN DISORDERS

Citation Acta Medica Nagasakiensia. 1992, 37

ENZYMES OF HEME METABOLISM IN THE KIDNEY Regulation by Trace Metals Which Do Not Form Heme Complexes*

Iron deficiency anemia and porphyrias

I coproporphyrinogen oxidase. Hereditary coproporphyria and epilepsy. I protoporphyrinogen oxidos.

Concise Review for Primary-Care Physicians

therapy and with normal erythrocyte porphobilinogen

Clinical diagnosis? AIP (Acute Intermittent Porphyria)

There are four types of acute porphyrias:

2013 OTS Annual Meeting Pre-clinical Development of ALN-AS1 RNAi Therapeutic for the Treatment of Acute Intermittent Porphyria.

Erythrocyte Uroporphyrinogen I Synthase Activity as an Indicator of Acute Porphyria

Porphyrias. Thomas A. Kruzel, N D

Directorate of Laboratory Medicine Blood Sciences Page 1 of 7 BS-CTG-Biochem-25 Revision Version: 1

Heme Biosynthesis and Porphyrin Studies in Chronic Renal Failure Patients Following Kidney Transplantation

Repression of the Overproduction of Porphyrin Precursors in Acute

The acute porphyrias are well-defined genetic disorders

Molecular and Biochemical Studies of Acute Intermittent Porphyria in 196 Patients and Their Families

Division of Preventive and Social Medicine, Department of Hygiene and Public Health Osaka Medical College, Takatsuki-city, Osaka , Japan

Acute Porphyria. Penelope Stein Haematological Medicine, King s College Hospital, London

PORPHYRIAS (Vampires and Crazy Kings)

Research Article Clinical and Laboratory Features of Acute Porphyria: A Study of 36 Subjects in a Chinese Tertiary Referral Center

الفريق االكاديمي الطبي HLS/ Biochemistry Sheet Porphyrin and Heme metabolism By: Shatha Khtoum

Dr sadeghi, MD Assistant professor of gastroenterology and hepatology

Fatal Neurological Manifestations of Acute Intermittent Porphyria

Decreased Red Cell Uroporphyrinogen I

STUDIES IN PORPHYRIA. VI. Biosynthesis of Porphyrins in Mammalian Skin and in the Skin of Porphyric Patients

Open-Label Study of Hemin for Acute Porphyria: Clinical Practice Implications

Screening Tests for Porphobilinogen Are Insensitive

The Atkins Diet as a Possible Trigger for an ICU Admission: A Case Report

Catecholamine Uptake, Accumulation, and Release

Treatment with Haematin in Acute Hepatic Porphyria

Clinical indications for the investigation of porphyria: case examples and evolving laboratory approaches to its diagnosis in New Zealand

STIMULATION OF HEMOGLOBIN SYNTHESIS IN CHICK

The porphyrias: a review

Variegate porphyria: an unusual cause of skin blistering

number Done by Corrected by Doctor Diala

Hereditary coproporphyria: incidence in a large

Case Report Feigning Acute Intermittent Porphyria

Iron and the Liver: Acute Effects of Iron-loading on Hepatic Heme Synthesis of Rats

administration,'2 a phenomenon previously demonstrated with certain [6-aminolevulinic acid (ALA) and porphobilinogen (PBG) ]1-6 and clinically

Abnormalities in Liver Function and Morphology and Impaired Aminopyrine Metabolism in Hereditary Hepatic Porphyrias

Research Institute, NC, USA. Journal of Exploratory Research in Pharmacology 2017 vol

ACUTE PORPHYRIAS: EMERGENCY ROOM RECOMMENDATIONS

Acute porphyrias : Diagnosis, complications and treatment options

Renal Mechanism for Excretion of Porphyrin Precursors in Patients with Acute Intermittent Porphyria and Chronic Lead Poisoning

Journal of Medical Genetics 1988, 25, patients with PCT remains unexplained. These

Communiqué. The Challenges of Testing For and Diagnosing Porphyrias

SAFE USE OF PERAMPANEL IN A CARRIER OF VARIEGATE PORPHYRIA: A CASE REPORT

PII S (99) Biochemical Differentiation of the Porphyrias

Correlation between some parameters of lead absorption and lead intoxication

Amino Acid Metabolism

BIOCHEMISTRY LECTURE BY OJEMEKELE O. BLOOD CHEMISTRY; BLOOD AS A TISSUE AND PORPHYRINS

26 June 2017 I ICPP I Bordeaux, France. Colin Living with Porphyria

26 June 2017 I ICPP I Bordeaux, France. Colin Living with Porphyria

Population studies on Gilbert's syndrome

Drug treatment in acute porphyria

Blood Lead Levels in Normal and Mentally Deficient

Presentations associated with porphyrias in intensive care units

Heterogeneity of Acute Intermittent Porphyria: A Subtype with Normal Erythrocyte Porphobilinogen Deaminase Activity in Germany 1 ), 2 )

Programme of community action in the field of health ( ) 2012 ACTIVITY REPORT DELIVERABLE 8: EVALUATION REPORT

pigment11-13 unrelated to destruction of the more mature circulating red cells.

Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection

Acute Intermittent Porphyria: Psychosis as the Only Clinical Manifestation

Paediatric Clinical Chemistry

Doaa Kotkot. Somaya Alkiswani. Nayef

DOWNLOAD PDF DIAGNOSIS AND THERAPY OF PORPHYRIAS AND LEAD INTOXICATION

When mixed as directed with Sterile Water for Injection, USP, each 48 ml provides the equivalent of approximately 336 mg hematin (7 mg/ml).

A Single Column Method for the Determination of Urinary -AminolevuIinic Acid

Update review of the acute porphyrias

Fitusiran and Givosiran Pipeline Updates

Neurological manifestations and molecular genetics of acute intermittent porphyria in North Western Russia

Composition of Urinary Coproporphyrin Isomers I IV in Human Porphyrias 1 )

The Diagnosis of Industrial Lead Poisoning

Porphyria in Japan : The Past, Present, and Future

Porphyrias in Norway 831 6

Porphyrias in Japan. Epidemiological Statistics of Porphyrias

Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium

Erythropoietic Porphyria of the

Pedigree Analysis Why do Pedigrees? Goals of Pedigree Analysis Basic Symbols More Symbols Y-Linked Inheritance

LATE ACUTE INTERMITTENT PORPHYRIA ATTACK IN A PATIENT WITH TYPE 2 DIABETES

Motor neuropathy in porphobilinogen deaminase deficient mice imitates the peripheral neuropathy of human acute porphyria

ANIMAL EXCRETION ANSWERS

Case Report Acute Intermittent Porphyria Associated with Respiratory Failure: A Multidisciplinary Approach

CHAPTER 27. Haem biosynthesis and the porphyrias. Jean-Charles Deybach, Laurent Gouya, Hervé Puy

Porphyria DNA Testing Laboratory Established by the APF

disorder The little imitator-porphyria: a neuropsychiatric REVIEW plants. The description of the porphyrins by

Urinary amino-acetone excretion in lead workers

Early Signs of Lead-exposure A comparative study of laboratory tests

SUMMARY OF PRODUCT CHARACTERISTICS. Human hemin mg/ml. One ampoule of 10 ml contains 250 mg human hemin.

Dosing, preparation, and infusion instructions

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD

Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyrias (AHPs) with Recurrent Attacks

Clinical and biochemical characteristics and genotype phenotype correlation in Finnish variegate porphyria patients

Porphyrias An Overview and Update for Physicians and their Staffs

Direct Assay of δ-aminolevulinic Acid Dehydratase in Heme Biosynthesis for the Detection of Porphyrias by Tandem Mass Spectrometry

International Journal of Scientific and Research Publications, Volume 6, Issue 11, November ISSN

Cutaneous Deposition Disorders

Transcription:

Journal of Medical Genetics, 1979, 16, 134-139 Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetasel JOEL M. LAMON, BRUCE C. FRYKHOLM, AND DONALD P. TCHUDY From the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014, UA UMMARY Acute intermittent porphyria (AIP) is a primary disorder of haem biosynthesis that is chemically characterised by raised urinary porphobilinogen (PBG). A defect in the biochemical pathway at the step of PBG conversion to uroporphyrinogen has been shown to be a result of a partial deficiency of the enzyme uroporphyrinogen I synthetase (uro I syn). The ascertainment rate of latent AIP (that is, chemically manifest but clinically asymptomatic) was examined in 185 individuals from 12 AIP kindreds using three parameters: red cell uro I syn, quantitative urinary PBG, and pedigree analysis with respect to uro I syn. Approximately 80 % of individuals could be assigned as normal or latent AIP on the basis of the uro I syn assay alone. The remaining 20 % could not be assigned because of an intermediate range of activity for the red cell assay in which the diagnosis cannot be certain. When the pedigree was used in the evaluation of the uro I syn data, the number of uncertain individuals, with respect to AIP, decreased to 10%. The enzyme method detected latent AIP in 37.5% of blood relatives, whereas quantitative urinary PBG alone detected only 15 *2 %. The pattern of inheritance for the uro I syn deficiency is consistent with Mendelian dominant inheritance, and it is likely that it is the basic inherited defect in AIP. Waldenstrom (1937) described the familial nature of acute intermittent porphyria (AIP) in weden. Autosomal dominant inheritance was suggested by this early study, which also showed that some asymptomatic family members excreted excess porphobilinogen in the urine. These chemically abnormal, but clinically asymptomatic, individuals were classified as having latent AIP. Later, Haeger- Aronsen (1958) suggested that the quantitative determination of urinary PBG and aminolaevulinic acid (ALA) would detect virtually all cases of latent AIP. Recently, a partial deficiency of approximately 50% of uroporphyrinogen I synthetase (uro I syn) has been associated with AIP (trand et al., 1970). This deficient uro I syn activity has been shown in liver tissue (trand et al., 1970), fibroblasts (Bonkowsky et al., 1975), lymphocytes (assa et al., 1977), and peripheral red cells (Magnussen et al., 1974) from patients with AIP. Evaluation of blood relatives of clinically affected AIP individuals using the red cell uro I syn assay revealed a higher rate of latent AIP than would have IPresented in part at the annual meeting of the American ociety of Human Genetics, October 1977. Received for publication 19 July 1978 been found using urinary PBG measurement alone. It was the purpose of this study to assess the efficacy of these two diagnostic tests for the identification of latent AIP in an affected kindred. Methods EXPERIMENTAL UBJECT The kindreds of 12 AIP patients were evaluated using quantitative 24-hour urinary PBG and red cell uro I syn assay. The index case in each kindred had clinically manifest ALP. Their biochemical evaluation showed raised urinary PBG (>2 mg/24 h) (8-8,tmol/24 h) and deficient red cell uro I syn activity (<23 nmol porphyrin/ml RBC per h). Red cell samples were obtained from 185 individuals and urine specimens from 173 of those. RED CELL UROPORPHYRINOGEN I YNTHETAE Approximately 10 ml heparinised blood was obtained by venipuncture. The red cells were washed with cold isotonic saline and the red cell pellet was stored at -40C. The assay was performed according to the method of Magnussen et al. (1974). Though an approximate 50% reduction in the uro I syn 134

....... Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen 1 synthetase 135 activity is present in AIP, a range of activities for the kindreds. The index cases are included in that Fig. red cell determination has been observed (Magnussen The suggestion that a bimodal distribution of uro I et al., 1974; assa et al., 1975; Bonkowsky and syn activity might occur within individual kindreds Bottomley, 1977). In this laboratory, the mean value (assa et al., 1975) was not observed. of uro I syn for normals was 39-8 ± 7-7 (D, The ascertainment rate for latent AIP within n = 37) nmol porphyrin/ml RBC per h and 18-6 ± kindreds at risk was 15-2 % when only the criterion 3 5 (D, n = 17) for AIP patients who had increased of a raised urinary PBG was used. Deficient uro I urinary PBG. The intermediate or uncertain range syn activity (< 23 nmol/ml RBC per h) was observed of uro I syn activity was established using empirical in 37 5 % of blood relatives tested. The improvement limits of the highest uro I syn activity in a patient in ascertainment of latent AIP using only the red with raised urinary PBG for the upper limit, and the cell uro I syn assay instead of urinary PBG was lowest uro I syn activity observed in a normal for significant (P < 0 0005) by the x2 test. The ascertainment rate using the uro I syn assay was improved the lower limit. by only 1-6% when urinary PBG information was QUANTITATIVE URINARY PBG also used (Fig. 3). This additional 1.6% represents The urinary PBG was measured from an aliquot of individuals with increased urinary PBG in addition a 24-hour urine collection by the method of to a uro I syn greater than 23 nmol porphyrin/ml Mauzerall and Granick, as modified by Marver RBC per h. Using an evaluation of the pedigree et al. (1966). with respect to the uro I syn activities improved the assignment of family members as normal with Results respect to AIP, and lowered the frequency of uncertain individuals by a half (Fig. 3). The frequency distribution of red cell uro I syn Using the concepts of simple Mendelian dominant activities among the family members, not including inheritance, the pedigrees were evaluated in two the index cases, is presented in Fig. 1. A bimodal ways: (1) by the use of parents' uro I syn activity distribution of enzyme activities, which would be to classify an offspring with intermediate uro I syn expected in a disease with a 50% deficiency in the activity into either normal or porphyria groups; and heterozygote, was not obvious. The possibility that (2) by the use of a clearly porphyric uro I syn interfamily variation in uro I syn activity might activity in an offspring to clarify the classification obscure such a distribution in the composite of 12 of a parent with intermediate uro I syn activity. kindreds was considered, and Fig. 2 depicts the Intermediate uro I syn activity (>23 and < 30 nmol distribution of uro I syn activities in the individual porphyrin/ml RBC per h) in offspring whose A B C 10 L. 9 E8... 7... _...............6......... f 5...... -I 0 2 1 FM- 0_._ I I-A U 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 Uro I syn (nmol porphyrin/ml RBC/hr) Fig. 1 Frequency distribution of red cell uro I syn activity in AlP family members. A, mean uro I syn for manifest AIP cases, 18.6 ± 3*5 nmol porphyrin/ml RBC per h (n = 17). B, intermediate range of uro I syn activity, >23 and <30 nmol porphyrin/ml RBC per h. C, mean uro I syn for normals, 39-8 ± 7 7 nmol porphyrin/ml RBC per h (n = 37)....... t _

136 en _ 50 46 42 38 34 _ 30 cr 26 v) _ - E 22 C-... cn > 18.c 14 &-a o E 10 _ 30--,I- 6 2 I * Denotes the index case 03 1 2 3 4 5 Individual families O' ** * * a. * ** 4! p.~~~ ** * * 5 i 0 *. ~ * : ** Latent AIP = Not certain = Normal (with resect to AI!P * 0. 6 7 8 ~ ~ ~ ~ ~ ~ ~ ~ 7 20 7 T 3~7.5 41.81 t39-11 ~41.8a 39 51 '-0 202 0L Erythrocyte Erythrocyte Er ythrocyte urol syn uro syn uro syr urine PBG urine P BG pedigree Fig. 3 Percentage of total cases (185) assigned as latent AIP, not certain, or normal, via three means of evaluation: (1) uro I syn activity only; (2) uro I syn activity plus 24-hour urinary PBG; and (3) uro I syn pedigree, as illustrated in Fig. 6.. *5; Lamon, Frykholm, and Tschudy 9 10 11 12 Fig. 2 Distribution of uro I syn activity in the 12 AIP kindreds studied. parents had unequivocally normal activity were considered normal; intermediate uro I syn activity in a parent of an individual with deficient activity was classified as latent AIP. The combination of normal uro I syn in both parents and deficient uro I syn activity in a child of these parents was not observed. An example of this approach can be seen in the pedigree (Fig. 4). Fig. 3 shows that this pedigree evaluation of uro I syn activity was most helpful in assigning uncertain individuals as normal with respect to ALP. Of the 12 index cases in this study, 11 were female. It is well known that manifest ALP is more frequent in females. Though the percentage in the intermediate group differed considerably from males to females, the ratio of porphyric to normal was compatible with Mendelian dominant inheritance of this defect. The detection rate of latent AIP by uro I syn measurement appears to be higher in females than in males (Fig. 5). Normal, deficient, and intermediate uro I syn activities were observed in family members of all ages, but no family member below the age of

Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase Unnary PBG ( mg/24hr) Erythrocyte uro syn (rfnol porphyrin/mi RBC/hr) Urinary PBG Erythrocyte uro syn 168 14-8 38-6 0-69 13 2 0-0 6-42 II O3 204 24 46-3 212 0 10sibs 1-04 1-04 29-2 229 / Index case Male Female Normal Urinary PBG 090 060 110 0-97 0-15 0-07 0-90 0-35 0-35 O (with respect to AIP) 0 Erythrocyte uro syn 616 38-1 39-2 19 2 19-1 19-6 16-9 10-7 284 * Manitest AIP * [U Latent AIP O Not certain (AIP & vs normal ) 0 Dead O 0 Not tested 0 Fig. 4 Pedigree of one of the 12 families studied. Red cell uro I syn and urinary PBG data are listed below the individual tested. a 50*- u3 40 -- a 30-0 20 - 'o = De&icient uro I syn = Intermediate uro I syn E= Normcl uro I syn Fema le mae 85 indiv!ducls '00 indiv!ducis Fig. 5 ex distribution of latent AIP and normal individuals. Percentage of total cases assigned as latent AIP or normal on the basis of uro I syn assay only. 24 excreted excess urinary PBG (Fig. 6). In Fig. 6 it can be seen that there is a striking contrast between the correlation of lowered enzyme and increased urinary PBG in individuals under the age of 24, as compared with those above this age. At enzyme levels below 15 nmol porphyrin/ml RBC per h, 100 4o of those above the age PBGF. Of 24 samples of urine were found in males. 52 50 48 46 44 42 400 E38, 36 34 O32 E _ 30 28 c26-24 22,20 18 16 14 12 10 8 6- of 24 had increased positive for PBG, 6 Maile Normacl ur.re PBG 0o Roised unne PBG (>2 mg,'24etr _~~~~~~~~~~~~~~-rjre rot sesed o * e 8 0 O 0sO O - 0 O ae ~~ _0 a 0 0 0 Oe O~~~~~~~ 0 'emrjle a 0 0,00 C' 01 0 00 - O 0 * 0 OP O * 00 0 0 00 0~ ~ ~ ~ ~. II0 4 8 12 16 20 24 28 32 36 O40 4 4<52 56 60 54 68 72 % 8c Age in years Fig. 6 Age vs. uro I syn activity. o 137

138 Discussion Demonstration of raised urine PBG excretion during the acute attack interval of AIP, as well as variegate and hereditary coproporphyria, continues to be the fundamental diagnostic parameter in the acute attack types of porphyria. Previously, quantitative 24-hour urinary PBG determination was the only objective parameter available to attempt to ascertain latent AIP within a kindred. This study confirms the impression that the measurement of uro I syn activity in an ALP kindred identifies a significantly larger number of individuals with latent AIP than the urine PBG evaluation. The hypothesis that a partial deficiency of uro I syn might be the basic inherited defect in AIP is supported by the current study. Waldenstrom (1937) postulated autosomal dominant inheritance for AIP based upon pedigree analysis of clinically affected and latent AIP (defined by raised urinary PBG) patients. Though more latent AIP cases were identified within these kindreds by uro I syn assay as compared to urine PBG measurement alone, the pattern of inheritance for the uro I syn deficiency remained consistent with Mendelian dominant inheritance. The equal distribution of normal and latent AIP among all family members (Fig. 3), and the approximately equal sex ratio (Fig. 5) using the uro I syn data, also support that hypothesis. The identification of a partial deficiency of uro I syn as the probable inherited defect in AIP has not improved the understanding of the pathogenesis of the clinically manifest disease. pecifically, the reasons why only some individuals with deficient uro I syn activity have increased urinary PBG (15 of 36 individuals in this study), and not all of those become symptomatic, are not known. ince all family members under the age of 24 were negative for urine PBG, as seen in Fig. 6, great decreases in the level of red cell uro l syn alone do not produce either chemical (increased urinary PBG) or clinical manifestations of the disease. This was the case even in the face of very low levels of the enzyme in some of these individuals. It has been known that children virtually never manifest the disease chemically or clinically. The present study not only confirms this, but shows that the difference between children and adults cannot be attributed to differences in enzyme level, at least with regard to the erythrocyte. Whether there are age differences in the activity of the liver enzyme is unknown. The present study further supports previous evidence that other factors, presumably hormonal, are necessary for the chemical and clinical manifestations of the disease (Tschudy, 1974). It would appear, therefore, that two conditions, the inherited deficiency of uro I syn and Lamon, Frykholm, and Tschudy adulthood, are necessary but not sufficient conditions for clinical activity of the disease. Clinical experience has shown that an acute exacerbation requires other factors in addition to these conditions (Tschudy, 1974). These factors include certain medications, starvation, infections, and an association with menstrual cycles in some females (Tschudy et al., 1975). Therefore, the identification of latent AIP individuals who may be at risk of developing an acute attack is important for the prevention of unnecessary morbidity and mortality. It is clear from this investigation that 80% of individuals in an AIP kindred can be classified as either latent ALP or normal by using red cell uro I syn assay. Quantitative 24-hour urinary PBG determinations on family members do not significantly improve the ascertainment of latent ALP beyond that achieved by the enzyme determination alone. For the approximately 20% of family members with uncertain uro I syn values, three approaches to achieve conclusive data are possible. Firstly, one can repeat the assay taking care that the reticulocyte count is not raised, that the blood sample is processed rapidly, and that adequate control and blank reactions are used. econdly, urinary PBG determination may be helpful in adults. Raised urinary PBG has been observed only in individuals older than 24 in this study. Thirdly, a pedigree analysis with respect to uro I syn can be used. This latter approach is described earlier. Using these methods 90% of an AIP kindred can be adequately evaluated for latent AIP. References Bonkowsky, H. L., and Bottomley,.. (1977). Evaluation of kindreds with acute intermittent porphyria: progress and problems. Clinical Research, 25, 517A. Bonkowsky, H. L., Tschudy, D. P., Weinbach, E. C., Ebert, P.., and Doherty, J. M. (1975). Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria. tudies using cultured human fibroblasts. Journal oflaboratory and Clinical Medicine, 85, 93-102. Haeger-Aronsen, B. (1958). Urinary 8-aminolaevulinic acid andporphobilinogen in different types of porphyria. Lancet, 2, 606-608. Magnussen, C. R., Levine, J. B., Doherty, J. M., Chessman, J. O., and Tschudy, D. P. (1974). A red cell enzyme method for the diagnosis of acute intermittent porphyria. Blood, 44, 857-868. Marver, H.., Tschudy, D. P., Perlroth, M. G., Collins, A., and Hunter, G., Jr. (1966). The determination of aminoketones in biological fluids. Analytical Biochemistry, 14, 53-60. assa,., Granick,., and Kappas, A. (1975). Effect of lead and genetic factors on heme biosynthesis in the human red cell. Annals of the New York Academy of ciences, 244, 419-440. assa,., Zalar, G. L., and Kappas, A. (1977). Deficient induction of uroporphyrinogen-i synthetase (URO-) activity in mitogen-stimulated lymphocytes from acute intermittent porphyria (AIP). Clinical Research, 25, 517A.

Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase trand, L. J., Felsher, B. F., Redeker, A. G., and Marver, H.. (1970). Heme biosynthesis in intermittent acute porphyria. Decreased hepatic conversion of porphobilinogen to porphyrins and increased delta-aminolevulinic acid synthetase activity. Proceedings ofthe National Academy of ciences of the U..A., 67, 1315-1320. Tschudy, D. P. (1974). Porphyrin metabolism and the porphyrias. In Duncan's Diseases of Metabolism, pp. 775-824. Ed. by P. K. Bondy, and L. E. Rosenberg. aunders, Philadelphia. Tschudy, D. P., Valsamis, M., and Magnussen, C. R. (1975). 139 Acute intermittent porphyria: clinical and selected research aspects. Annals of Internal Medicine, 83, 851-864. Waldenstrom, J. (1937). tudien uber porphyrie. Acta Medica candinavica, uppl. 82, 1-254. Requests for reprints to Dr Joel M. Lamon, Clinical Epidemiology Branch, National Cancer Institute, A521 Landow Building, National Institutes of Health, Bethesda, Maryland 20014, UA. J Med Genet: first published as 10.1136/jmg.16.2.134 on 1 April 1979. Downloaded from http://jmg.bmj.com/ on 8 eptember 2018 by guest. Protected by copyright.